EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Label‐Free Assessment of Mesenchymal Stem Cell Quality by AI‐Driven Analysis of High‐Throughput Morphological Diversity

Di Wu iD, Fan Yang, Wenwen Li, Lu Lu iD, Ya Sun, Zexuan Zhang, Xiaohan Sun iD, Fangcao Lei, Lingzi Liao iD, Xueli Mao iD, Songtao Shi iD

Advanced Science · 15.11.2026

DOI: 10.1002/advs.78705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.11.2026. Verfasst von Di Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guanghua School of Stomatology, South China Center of Craniofacial Stem Cell Research, Hospital of Stomatology, Guangdong Provincial Key Laboratory o…. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Pearl River Talent Recruitment Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advancement of mesenchymal stem cells (MSCs) therapies is constrained by the absence of rapid, non‐destructive quality assessment methods. Here, we present FlowAIQ, an artificial intelligence (AI)‐driven platform for label‐free evaluation of MSCs potency. Our method quantitatively analyzes population‐wide morphological heterogeneity captured from millions of single cells via high‐throughput flow cytometry. We model each sample as a Gaussian mixture distribution to extract holistic biophysical descriptors. A constrained multilayer perceptron learns a nonlinear mapping from these descriptors to a quantitative functional potency index. This approach demonstrates high predictive accuracy, with outputs suggestive of therapeutic efficacy in osteoporosis and colitis mouse models. SHAP analysis identifies key morphological features underlying predictions, providing interpretability of cellular phenotypic diversity. We define AI‐derived morphological diversity as a digital biomarker of cell potency. Our work establishes an AI‐powered framework for label‐free stem cell quality control with translational potential.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecell therapydigital biomarkerheterogeneous morphological diversitylabel‐free assessmentpredictive modelingstem cell quality control

Autor:innen und Institutionen

  • Guanghua School of Stomatology, South China Center of Craniofacial Stem Cell Research, Hospital of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, China.
  • Zhongshan Institute for Drug Discovery, Institutes of Drug Discovery and Development Chinese Academy of Sciences, Zhongshan, China.
  • Department of Biochemistry and Molecular Biology, State Key Laboratory of Common Mechanism Research for Major Diseases, School of Basic Medicine Peking Union Medical College, Institute of Basic Medical Sciences Chinese…
  • Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
  • Center For Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Di Wu, Lu Lu, Xiaohan Sun, Lingzi Liao, Xueli Mao, Songtao Shi

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Pearl River Talent Recruitment Program
  • Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Wu, D., Yang, F., Li, W., Lu, L., Sun, Y., Zhang, Z., Sun, X., Lei, F., Liao, L., Mao, X., & Shi, S. (2026). Label‐Free Assessment of Mesenchymal Stem Cell Quality by AI‐Driven Analysis of High‐Throughput Morphological Diversity. Advanced Science. https://doi.org/10.1002/advs.78705

Vancouver

Wu D, Yang F, Li W, Lu L, Sun Y, Zhang Z, et al. Label‐Free Assessment of Mesenchymal Stem Cell Quality by AI‐Driven Analysis of High‐Throughput Morphological Diversity. Advanced Science. 2026. doi:10.1002/advs.78705

BibTeX
@article{Wu2026,
  author = {Wu, Di and Yang, Fan and Li, Wenwen and Lu, Lu and Sun, Ya and Zhang, Zexuan and Sun, Xiaohan and Lei, Fangcao and Liao, Lingzi and Mao, Xueli and Shi, Songtao},
  title = {Label‐Free Assessment of Mesenchymal Stem Cell Quality by AI‐Driven Analysis of High‐Throughput Morphological Diversity},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78705}
}
Kostenlos starten →